KUALA LUMPUR, Feb 7 — Malaysia has recorded losses exceeding RM260 million to commercial crimes in the first 33 days of 2025, ...
Results of multi-institutional clinical study published in peer reviewed journal 'Cancers' confirms efficacy ofOxford BioDynamics' EpiSwitch blood-based Colorectal No-Stool Test (NST) High ...
Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces the publication of compelling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback